Icariin promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells in patients with osteoporosis and T2DM by upregulating GLI-1

Abstract Background The function of mesenchymal stem cells (MSCs) from patients with osteoporosis (OP) is impaired and worsens in patients with type 2 diabetes mellitus (T2DM). Icariin (ICA) is the major active flavonoid glucoside isolated from traditional Chinese herbal Epimedium pubescens, and con...

Full description

Bibliographic Details
Main Authors: Sheng-li Xia, Zi-yuan Ma, Bin Wang, Feng Gao, Sheng-yang Guo, Xu-han Chen
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Online Access:https://doi.org/10.1186/s13018-023-03998-w
_version_ 1797778769952374784
author Sheng-li Xia
Zi-yuan Ma
Bin Wang
Feng Gao
Sheng-yang Guo
Xu-han Chen
author_facet Sheng-li Xia
Zi-yuan Ma
Bin Wang
Feng Gao
Sheng-yang Guo
Xu-han Chen
author_sort Sheng-li Xia
collection DOAJ
description Abstract Background The function of mesenchymal stem cells (MSCs) from patients with osteoporosis (OP) is impaired and worsens in patients with type 2 diabetes mellitus (T2DM). Icariin (ICA) is the major active flavonoid glucoside isolated from traditional Chinese herbal Epimedium pubescens, and confirmed able to improve bone mass of OP patients. Objective To investigate the effect of ICA on the proliferation and osteogenic differentiation of bone-derived MSCs (BMSCs) from patients with OP and T2DM and uncover the potential mechanism. Methods BMSCs were treated with ICA, and proliferation and osteogenic potency were evaluated using the 2,5-diphenyl-2H-tetrazolium bromide (MTT) assay and detection of osteogenic markers (ALP, RUNX2, SPP1, COL1A1, and mineralized nodules) was performed. RNA sequencing and bioinformatic analysis were performed to identify differentially expressed genes (DEGs) after ICA treatment and screen proliferation- and osteogenic differentiation-related processes. Gene gain and loss were performed to confirm the role of the key candidate gene. Results ICA significantly promoted the proliferation and osteogenic differentiation of BMSCs. A total of 173 DEGs were identified after ICA treatment. Six DEGs (GLI-1, IGF2, BMP6, WNT5A, PTHLH, and MAPK14) enriched in both proliferation- and osteogenic differentiation-related processes were screened; GLI-1 had the highest validated |log2FC| value. Overexpression of GLI-1 enhanced the proliferation and osteogenic differentiation of BMSCs, and knockdown of GLI-1 weakened the positive effect of ICA on BMSCs. Conclusion ICA promoted the proliferation and osteogenic differentiation of impaired BMSCs by upregulating GLI-1.
first_indexed 2024-03-12T23:22:19Z
format Article
id doaj.art-767e65cdb63b4da5b3bba0629ab08b2f
institution Directory Open Access Journal
issn 1749-799X
language English
last_indexed 2024-03-12T23:22:19Z
publishDate 2023-07-01
publisher BMC
record_format Article
series Journal of Orthopaedic Surgery and Research
spelling doaj.art-767e65cdb63b4da5b3bba0629ab08b2f2023-07-16T11:23:00ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2023-07-0118111210.1186/s13018-023-03998-wIcariin promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells in patients with osteoporosis and T2DM by upregulating GLI-1Sheng-li Xia0Zi-yuan Ma1Bin Wang2Feng Gao3Sheng-yang Guo4Xu-han Chen5Department of Orthopedics, Shanghai University of Medicine and Health Sciences Affiliated Zhoupu HospitalDepartment of Orthopedics, Shanghai University of Medicine and Health Sciences Affiliated Zhoupu HospitalDepartment of Orthopedics, Shanghai University of Medicine and Health Sciences Affiliated Zhoupu HospitalDepartment of Orthopedics, Shanghai University of Medicine and Health Sciences Affiliated Zhoupu HospitalDepartment of Orthopedics, Shanghai University of Medicine and Health Sciences Affiliated Zhoupu HospitalZhoupu Community Health Service CenterAbstract Background The function of mesenchymal stem cells (MSCs) from patients with osteoporosis (OP) is impaired and worsens in patients with type 2 diabetes mellitus (T2DM). Icariin (ICA) is the major active flavonoid glucoside isolated from traditional Chinese herbal Epimedium pubescens, and confirmed able to improve bone mass of OP patients. Objective To investigate the effect of ICA on the proliferation and osteogenic differentiation of bone-derived MSCs (BMSCs) from patients with OP and T2DM and uncover the potential mechanism. Methods BMSCs were treated with ICA, and proliferation and osteogenic potency were evaluated using the 2,5-diphenyl-2H-tetrazolium bromide (MTT) assay and detection of osteogenic markers (ALP, RUNX2, SPP1, COL1A1, and mineralized nodules) was performed. RNA sequencing and bioinformatic analysis were performed to identify differentially expressed genes (DEGs) after ICA treatment and screen proliferation- and osteogenic differentiation-related processes. Gene gain and loss were performed to confirm the role of the key candidate gene. Results ICA significantly promoted the proliferation and osteogenic differentiation of BMSCs. A total of 173 DEGs were identified after ICA treatment. Six DEGs (GLI-1, IGF2, BMP6, WNT5A, PTHLH, and MAPK14) enriched in both proliferation- and osteogenic differentiation-related processes were screened; GLI-1 had the highest validated |log2FC| value. Overexpression of GLI-1 enhanced the proliferation and osteogenic differentiation of BMSCs, and knockdown of GLI-1 weakened the positive effect of ICA on BMSCs. Conclusion ICA promoted the proliferation and osteogenic differentiation of impaired BMSCs by upregulating GLI-1.https://doi.org/10.1186/s13018-023-03998-wIcariinT2DMGLI-1Osteogenic differentiationOsteoporosis
spellingShingle Sheng-li Xia
Zi-yuan Ma
Bin Wang
Feng Gao
Sheng-yang Guo
Xu-han Chen
Icariin promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells in patients with osteoporosis and T2DM by upregulating GLI-1
Journal of Orthopaedic Surgery and Research
Icariin
T2DM
GLI-1
Osteogenic differentiation
Osteoporosis
title Icariin promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells in patients with osteoporosis and T2DM by upregulating GLI-1
title_full Icariin promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells in patients with osteoporosis and T2DM by upregulating GLI-1
title_fullStr Icariin promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells in patients with osteoporosis and T2DM by upregulating GLI-1
title_full_unstemmed Icariin promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells in patients with osteoporosis and T2DM by upregulating GLI-1
title_short Icariin promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells in patients with osteoporosis and T2DM by upregulating GLI-1
title_sort icariin promotes the proliferation and osteogenic differentiation of bone derived mesenchymal stem cells in patients with osteoporosis and t2dm by upregulating gli 1
topic Icariin
T2DM
GLI-1
Osteogenic differentiation
Osteoporosis
url https://doi.org/10.1186/s13018-023-03998-w
work_keys_str_mv AT shenglixia icariinpromotestheproliferationandosteogenicdifferentiationofbonederivedmesenchymalstemcellsinpatientswithosteoporosisandt2dmbyupregulatinggli1
AT ziyuanma icariinpromotestheproliferationandosteogenicdifferentiationofbonederivedmesenchymalstemcellsinpatientswithosteoporosisandt2dmbyupregulatinggli1
AT binwang icariinpromotestheproliferationandosteogenicdifferentiationofbonederivedmesenchymalstemcellsinpatientswithosteoporosisandt2dmbyupregulatinggli1
AT fenggao icariinpromotestheproliferationandosteogenicdifferentiationofbonederivedmesenchymalstemcellsinpatientswithosteoporosisandt2dmbyupregulatinggli1
AT shengyangguo icariinpromotestheproliferationandosteogenicdifferentiationofbonederivedmesenchymalstemcellsinpatientswithosteoporosisandt2dmbyupregulatinggli1
AT xuhanchen icariinpromotestheproliferationandosteogenicdifferentiationofbonederivedmesenchymalstemcellsinpatientswithosteoporosisandt2dmbyupregulatinggli1